- Home
- CSTE vs NRSN Comparison
CSTE vs NRSN Comparison
Compare CSTE & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTE
- NRSN
- Stock Information
- Founded
- CSTE 1987
- NRSN 2017
- Country
- CSTE Israel
- NRSN Israel
- Employees
- CSTE N/A
- NRSN N/A
- Industry
- CSTE Building Materials
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- CSTE Industrials
- NRSN Health Care
- Exchange
- CSTE Nasdaq
- NRSN Nasdaq
- Market Cap
- CSTE 61.9M
- NRSN 50.1M
- IPO Year
- CSTE 2012
- NRSN 2021
- Fundamental
- Price
- CSTE $1.52
- NRSN $1.19
- Analyst Decision
- CSTE
- NRSN Buy
- Analyst Count
- CSTE 0
- NRSN 2
- Target Price
- CSTE N/A
- NRSN $14.00
- AVG Volume (30 Days)
- CSTE 62.3K
- NRSN 434.6K
- Earning Date
- CSTE 08-06-2025
- NRSN 09-29-2025
- Dividend Yield
- CSTE N/A
- NRSN N/A
- EPS Growth
- CSTE N/A
- NRSN N/A
- EPS
- CSTE N/A
- NRSN N/A
- Revenue
- CSTE $406,178,000.00
- NRSN N/A
- Revenue This Year
- CSTE N/A
- NRSN N/A
- Revenue Next Year
- CSTE $6.60
- NRSN N/A
- P/E Ratio
- CSTE N/A
- NRSN N/A
- Revenue Growth
- CSTE N/A
- NRSN N/A
- 52 Week Low
- CSTE $1.52
- NRSN $0.67
- 52 Week High
- CSTE $5.28
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- CSTE 32.95
- NRSN 35.29
- Support Level
- CSTE $1.52
- NRSN $1.03
- Resistance Level
- CSTE $1.76
- NRSN $1.31
- Average True Range (ATR)
- CSTE 0.14
- NRSN 0.22
- MACD
- CSTE -0.02
- NRSN -0.03
- Stochastic Oscillator
- CSTE 0.00
- NRSN 17.43
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.